FEBURIC

Serial Number 97407235
734

Registration Progress

Application Filed
May 12, 2022
Under Examination
Jun 13, 2023
Approved for Publication
Apr 18, 2023
Published for Opposition
Apr 18, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jun 13, 2026 155 days
Statement of Use required (all extensions used)

Trademark Image

FEBURIC

Basic Information

Serial Number
97407235
Filing Date
May 12, 2022
Published for Opposition
April 18, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Dec 9, 2025
Application
Pending
Classes
005

Rights Holder

Teijin Pharma Limited

03
Address
2-1, Kasumigaseki 3-chome, Chiyoda-ku
Tokyo 100-0013
JP

Ownership History

Teijin Pharma Limited

Original Applicant
03
Tokyo JP

Teijin Pharma Limited

Owner at Publication
03
Tokyo JP

Legal Representation

Attorney
LEIGH ANN LINDQUIST

USPTO Deadlines

Next Deadline
155 days remaining
NOA E-Mailed - SOU Required
Due Date
June 13, 2026

Application History

32 events
Date Code Type Description Documents
Dec 10, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 9, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 25, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 15, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 15, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
May 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 3, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 18, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 3, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 18, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 14, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 29, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 29, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 13, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 18, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 29, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 12, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 1, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 31, 2022 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
May 28, 2022 ALIE A ASSIGNED TO LIE Loading...
May 23, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
May 17, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 16, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of hyperuric and gout

Classification

International Classes
005